Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.
- DOI
- 10.1002/jimd.70151
- Published
- 2026 Mar
- Container
- Journal of inherited metabolic disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jimd.70151,
title = {Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.},
author = {Curry DJ and Pearl PL and Stone SSD and Gilbert DL and Vadivelu S and Ben-Zeev B and Vestal M and Zafar M and Tai CH and Chou SC and Zibly Z and Ungar L and Parnes M and Hull M and Emrick L and Werner C and Krolick A and Penematsa V and Wang A and Rahman R and Golden L and Chien YH and Hwu PW},
year = {2026},
journal = {Journal of inherited metabolic disease},
doi = {10.1002/jimd.70151},
url = {https://doi.org/10.1002/jimd.70151}
}RIS
TY - JOUR TI - Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up. AU - Curry DJ AU - Pearl PL AU - Stone SSD AU - Gilbert DL AU - Vadivelu S AU - Ben-Zeev B AU - Vestal M AU - Zafar M AU - Tai CH AU - Chou SC AU - Zibly Z AU - Ungar L AU - Parnes M AU - Hull M AU - Emrick L AU - Werner C AU - Krolick A AU - Penematsa V AU - Wang A AU - Rahman R AU - Golden L AU - Chien YH AU - Hwu PW PY - 2026 JO - Journal of inherited metabolic disease DO - 10.1002/jimd.70151 UR - https://doi.org/10.1002/jimd.70151 ER -
APA
DJ, C., PL, P., SSD, S., DL, G., S, V., B, B., M, V., M, Z., CH, T., SC, C., Z, Z., L, U., M, P., M, H., L, E., C, W., A, K., V, P., A, W., R, R., L, G., YH, C., & PW, H. (2026). Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.. Journal of inherited metabolic disease. https://doi.org/10.1002/jimd.70151
Source records
- pubmed · retrieved 2026-09-27T07:46:26.933Z